MEDLIB-L Archives

February 2019, Week 3

MEDLIB-L@LIST.UVM.EDU

Options: Use Proportional Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Lubenow Janis <[log in to unmask]>
Reply To:
Lubenow Janis <[log in to unmask]>
Date:
Wed, 20 Feb 2019 19:59:00 +0000
Content-Type:
text/plain
Parts/Attachments:
text/plain (33 lines)
Is anyone able to supply FREE of charge?                  Docline says this UI is not found
Thanks in advance for your time…:)
Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies. <http://ovidsp.tx.ovid.com/sp-3.32.2a/ovidweb.cgi?&S=HDLGFPPEHNDDCJKFNCDKIEOBCPENAA00&Complete+Reference=S.sh.25%7c1%7c1&Counter5=SS_view_found_complete%7c27535349%7cppez%7cmedline%7cmed12&Counter5Data=27535349%7cppez%7cmedline%7cmed12>
Di Nisio M; Vedovati MC; Riera-Mestre A; Prins MH; Mueller K; Cohen AT; Wells PS; Beyer-Westendorf J; Prandoni P; Bounameaux H; Kubitza D; Schneider J; Pisters R; Fedacko J; Fontes-Carvalho R; Lensing AW.
Thrombosis & Haemostasis. 116(4):739-46, 2016 09 27.
[Journal Article. Randomized Controlled Trial]
UI: 27535349




Janis Lubenow
Library Information Specialist/CME Coordinator
UP Health System - Marquette
Health Sciences Library
580 W. College Ave.
Marquette, MI 49855
(906) 225-3429

[log in to unmask]<mailto:[log in to unmask]>

http://www.mgh.org/for-healthcare-professionals/health-sciences-library



[cid:image001.jpg@01D336DB.784B60E0]

P Think Green - Print only when it's necessary



The information transmitted via this e-mail is intended only for the person or entity to which it is addressed and may contain confidential and/or proprietary information. Any use, review, retransmission, dissemination or other use of, or pursuing of any action in reliance upon this information by persons or entities other than the intended recipient is strictly prohibited. If you are the recipient of this e-mail transmission in error, please reply to the sender and delete the material from any computer. Thank you.

ATOM RSS1 RSS2